Prokidney (PROK) Return on Sales (2024 - 2026)

Prokidney's (PROK) quarterly Return on Sales came in at 1.89% in Q1 2026, down 24.0% year-on-year from 2.48% in Q1 2025, and down 388.51% on a QoQ basis from 0.39% in Q4 2025.

Prokidney (PROK) Return on Sales (2024 - 2026) Analysis & Trends

Prokidney (PROK) has 3 years of Return on Sales data on file, last reported at 1.89% in Q1 2026.

  • On a quarterly basis, Return on Sales fell 24.0% year-over-year to 1.89% in Q1 2026; TTM through Mar 2026 was 1.4%, a 403.0% increase from a year earlier, with the FY2025 full-year figure at 1.34%, up 2015.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 1.89%, down from 0.39% in the prior quarter.
  • Over the last five years, Return on Sales for PROK reached as high as 0.39% in Q4 2025 and fell as low as 6.38% in Q4 2024.
  • Historically, Return on Sales has averaged 2.27% across 3 years, with a median of 1.66% in 2025.
  • Across the five-year window, Return on Sales jumped 599 bps in 2025 and dropped 24 bps in 2026, its largest moves.
  • Year by year, Return on Sales stood at 6.38% in 2024, then surged by 94 bps to 0.39% in 2025, then tumbled by 389 bps to 1.89% in 2026.
  • Per Business Quant data, the three most recent Return on Sales figures were 1.89% in Q1 2026, 0.39% in Q4 2025, and 1.65% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.00%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.00%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Prokidney 96.00 Mn 96.00 Mn - -1.89%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.89%
Dec 31, 2025 -0.39%
Sep 30, 2025 -1.65%
Jun 30, 2025 -1.67%
Mar 31, 2025 -1.65%
Dec 31, 2024 -6.38%